| | Class 2 Device Recall Flow Anesthesia Machine |  |
| Date Initiated by Firm | June 24, 2026 |
| Date Posted | August 03, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-2860-2026 |
| Recall Event ID |
99359 |
| 510(K)Number | K191027 |
| Product Classification |
Gas-machine, anesthesia - Product Code BSZ
|
| Product | Flow Anesthesia Machine
Flow-i C20 6677200
Flow-i C30 6677300
Flow-i C40 6677400
Flow-i C20 6888520
Flow-i C30 6888530
Flow-i C40 6888540
Flow-c 6887700
Flow-e 6887900 |
| Code Information |
Flow-i C20 6677200 / UDI-DI 07325710001349
Flow-i C30 6677300 / UDI-DI 07325710001363
Flow-i C40 6677400 / UDI-DI 07325710001318
Flow-i C20 6888520 / UDI-DI 07325710010617
Flow-i C30 6888530 / UDI-DI 07325710010624
Flow-i C40 6888540 / UDI-DI 07325710010631
Flow-c 6887700 / UDI-DI 07325710009765
Flow-e 6887900 / UDI-DI 07325710010457
Software versions 4.8, 4.10, and 4.11. |
| FEI Number |
3002808128
|
Recalling Firm/ Manufacturer |
Maquet Critical Care AB Rontgenvagen 2 Solna Sweden
|
| For Additional Information Contact | Megan Ties 103357300 |
Manufacturer Reason for Recall | Events observed where anesthetic agent was not delivered when the vaporizer was activated. Failure to deliver the anesthetic agent may result in the patient receiving insufficient anesthesia and may lead to intraoperative awareness. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | On June 24, 2026, the firm began issuing "Urgent Medical Device Correction" letters via FedEx to customers at the Risk Manager level.
Customers were informed that according to the Instructions for Use, this indication signifies that concentration levels are below detectable limits, serving as confirmation that no agent is present: **/gas analyzer has no information to display
Customers were given recommended precautions to identify and mitigate the issue, such as confirming that the anesthetic agent is being delivered after activating the vaporizer, and continuously monitoring end-tidal anesthetic agent concentration and patient vital signs to ensure adequate anesthesia is maintained. If delivery is not confirmed, end case and start up again.
The firm has developed a software update, version 4.8.7, which will improve stability during case start-up, thereby reducing the risk of no anesthetic agent delivery events.
Customers are instructed to identify all affected product in their inventory and notify any individuals within their organization or where the affected devices have been transferred.
Customers should contact their local Getinge representative to assist with downloading the updated software. |
| Quantity in Commerce | 408 US; 11,342 OUS |
| Distribution | Worldwide - US Nationwide distribution to the states of AL, AR, CA, CO, DC, DE, FL, GA, IN,
MA, MI, MO, NY, OH, OR, PA, SC, TX, VA, WA, WV. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = BSZ
|
|
|
|